Additionally, This will be a world first in the 3rd largest chronic disease on the planet. This device could help put a huge dent in the vast Healthcare expenditure on managing and treating asthma which is what they have all been screaming out for. Don’t forget the piece of mind this device will give to parents of asthmatics and asthma sufferers themselves!!. If they charged $100-200 a pop who wouldn’t buy one? ... that’s why we are investors!
Worth the wait!
RSH Price at posting:
7.2¢ Sentiment: Buy Disclosure: Held
